Drugs for BNCT: BSH and BPA

Wolfgang A.G. Sauerwein*, Pierre M. Bet, Andrea Wittig

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate the preparation of new clinical trials based on these compounds. However, this compilation cannot offer a complete and final description of all aspects concerning these 2 compounds necessary to file for drug approval.

Original languageEnglish
Title of host publicationNeutron Capture Therapy
Subtitle of host publicationPrinciples and Applications
PublisherSpringer-Verlag Berlin Heidelberg
Pages117-160
Number of pages44
Volume9783642313349
ISBN (Electronic)9783642313349
ISBN (Print)3642313337, 9783642313332
DOIs
Publication statusPublished - 1 Aug 2012

Cite this